TipRanks
BeOne Medicines (DE:49BA)
FRANKFURT:49BA

Compare BeOne Medicines (49BA) vs. Competitors

4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
BeOne Medicines
€318.00
€35.14B
24.93
9.15%
13 Buy
0 Hold
0 Sell
Strong Buy
Exelixis
$56.72
$14.83B
18.19
56.80%
3 Buy
9 Hold
1 Sell
Hold
Incyte
$128.12
$22.86B
13.87
32.89%
11 Buy
10 Hold
0 Sell
Moderate Buy
Summit Therapeutics
$14.23
$14.07B
-15.71
-19.77%
10 Buy
6 Hold
0 Sell
Moderate Buy
Zai Lab
$26.82
$2.79B
-14.07
-18.68%
3 Buy
0 Hold
0 Sell
Strong Buy
Genmab
$34.36
$21.92B
28.63
17.48%
9 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:49BA
BeOne Medicines
310.00
30.00
10.71%
EXEL
Exelixis
59.82
21.38
55.62%
INCY
Incyte
111.36
26.63
31.43%
SMMT
Summit Therapeutics
17.13
-5.80
-25.29%
ZLAB
Zai Lab
24.59
-6.64
-21.26%
GMAB
Genmab
37.37
4.69
14.35%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts